Home›Companies›Healthcare›Throne

Throne, Inc.

Throne makes a clip-on toilet sensor and app that track stool, urine and hydration for households, people with gut conditions and senior-living communities.

Updated Nov 5, 2026·Latest SEC filing Jun 2, 2026·Suggest an edit

About Throne

Throne makes a sensor that clips onto a home toilet, plus an app that reads its data. Its camera faces down into the bowl, and AI classifies stool form and color and estimates volume. It also reads urine color to score hydration. Throne sells to consumers, including people with IBS or IBD, and to senior-living communities.

Throne is headquartered in Austin, Texas, and began selling to consumers in March 2026. The device costs $399, and membership costs $6 a month per person after the first three months. Co-founder Scott Hickle is CEO. His co-founders are Tim Blumberg and John Capodilupo, who also co-founded WHOOP and was its CTO for 10 years. In July 2026, Will Ventures led Throne's $10 million Series A.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 11, 2026Jun 2, 2026$16,073,488of $17.7M target47$341KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Rounds announced by Throne

What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.

AnnouncedRoundAmountInvestorsSource
Jul 28, 2026Series A$10MWill Ventures (lead), Emerson Collective, Workshop, LEAD VC, Salt VC, Accomplice, Moxxie, Ventures Together, Symphony, Felix Capital, Cosmic Venture Partners, Offscript, V1.VC, Morrison Segerthronescience.com ↗
Press release ↗
May 22, 2025Seed$4MMoxxie Ventures (lead), Accomplice, Long Journey Ventures, V1.VC, Night Capital, Retron VC, Myelin Ventures, Lance Armstrong, Tara Viswanathan, Justin MaresTechCrunch ↗
Moxxie ↗

Why Investors Backed Throne

Investors backed Throne because it tracks a part of health that wearables still miss. Its sensor clips onto a toilet and records stool and urine at every visit, with no logging. Ben Gardner of Will Ventures, which led the Series A, called gut data "one of the richest sources of health data available." Backers also point to the team and to the chance of spotting health problems earlier.

The problem it targets

People can choose from many devices that track sleep and heart rate. However, "gut health, hydration and urinary function are still, by and large, a black box," CEO Scott Hickle told MedCity News. Doctors also rely on what patients remember about their bowel habits. Gardner put it simply: "we have no way to track and optimize our gut health habits today." The stakes can be high. According to MedCity News, colorectal cancer now kills more U.S. adults under 50 than any other cancer.

What the product does

Throne clips onto the toilet, and its camera points only into the bowl. It records a visit only when it recognizes the user's phone or the user presses a button, so it ignores guests. AI classifies stool on the Bristol Stool Scale and reads urine color to score hydration. For people who stand to pee, it also listens to the stream to estimate urine flow. One device serves up to six people. In the app, a Gut Health Coach looks for links between bad gut days and food, stress or travel.

Progress so far

Throne started selling to consumers in March 2026. Its first validation study compared its AI with five board-certified gastroenterologists on 278 stool photos. The AI agreed with the doctors about as closely as the doctors agreed with each other. The American College of Gastroenterology accepted the study for its 2026 annual meeting.

Who backs it

Will Ventures, a Boston firm, led the $10 million Series A in July 2026. Emerson Collective, Workshop, Accomplice, Moxxie and nine other investors joined. Will Ventures managing partner Ben Gardner is also a director at Throne. Emerson Collective's Fern Mandelbaum said Throne creates a baseline that "can help doctors identify meaningful changes and detect potential health issues earlier." Earlier, Moxxie Ventures, founded by Katie Jacobs Stanton, led a $4 million seed round in May 2025. In total, Throne has raised nearly $18 million, MedCity News reports.

How the market is moving

Big bathroom brands are moving into the same space. Kohler Health launched Dekoda, a $449 clip-on toilet sensor, in October 2025. Kohler says Dekoda is the only toilet-based tracker on the market that can detect blood in the bowl. Toto sells Stool Scan in premium toilets in Japan and plans a US launch in early 2027, Business Insider reported. Withings and Vivoo sell devices that test urine. Brian Comiskey of the Consumer Technology Association told Business Insider that the category began taking off in 2023.

We wrote this summary from public statements by Throne and its investors. It is not investment advice.

Throne in the News

Leadership Team

Executive officers and directors listed on Throne's Form D filed Jun 2, 2026.

TB
Timothy Blumberg
Co-founder and director
BG
Ben Gardner
Director · Managing Partner, Will Ventures
SH
Scott Hickle
Co-founder and CEO, director
Listed as Randall Hickle II on the Form D.

Sources

  1. SECThrone, Inc. filing history
  2. Companythronescience.com, About Us
  3. Companythronescience.com, Throne One product page
  4. Companythronescience.com, The science (validation study)
  5. Companythronescience.com, Senior living
  6. Companythronescience.com, Terms of Service
  7. Companythronescience.com, blog: From WHOOP to Throne (2025-09-26)
  8. PressTechCrunch, Will Ventures second fund (2022-10-18)
  9. PressPR Newswire, Kohler Health Dekoda anniversary (2026-10-15)
  10. Investorwillventures.com, team (Ben Gardner)